Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Advances in Virology is Scopus-indexed (Q3, CiteScore 2.9), WoS ESCI, DOAJ. Published by John Wiley and Sons Ltd.
Checked against the index lists dated .
ISSN 1687-8639Verify ISSN ↗1687-8647Verify ISSN ↗
Publisher: John Wiley and Sons Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Infectious Diseases | 201 / 361 | 44th | Q3 |
| Virology | 56 / 86 | 35th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2009–present, best quartile Q3, CiteScore 2.9.
Advances in Virology is Q3 in Infectious Diseases (rank 201 of 361) and Q3 in Virology (rank 56 of 86), by CiteScore 2025.
Advances in Virology is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.9, which places it in quartile Q3 at the 44th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.402, quartile Q3, with an H-index of 33.
The publisher lists an article processing charge of about US$1,000 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Advances in Virology is published by John Wiley and Sons Ltd. Its print ISSN is 1687-8639 and its online ISSN is 1687-8647.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Advances in Virology has an h-index of 38 and a 2-year mean of 1.85 citations per paper (OpenAlex). Its Scopus CiteScore is 2.9, quartile Q3. On 2-year citations it ranks #171 of 354 Scopus journals in Infectious Diseases.
Advances in Virology published 20 papers in 2025; its busiest recent year was 2022 with 27. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 88 research articles (2021–2026), authors are most often from Iraq (10%), United States (8.9%) and Iran (6.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (7.5 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.